140
Views
10
CrossRef citations to date
0
Altmetric
Review

Cardiorespiratory fitness and sleep-related breathing disorders

, , , &
Pages 745-758 | Published online: 10 Jan 2014

References

  • Banno K, Kryger MH. Sleep apnea: clinical investigations in humans. Sleep Med.8, 400–426 (2007).
  • Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328, 1230–1235 (1993).
  • Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: I. Prevalence and severity. Am. J. Respir. Crit. Care Med.157, 144–148 (1998).
  • Kapur V, Strohl KP, Redline S et al. Underdiagnosis of sleep apnea syndrome in US communities. Sleep Breath.6, 49–54 (2002).
  • Fung JW, Li TS, Choy DK et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest121, 422–429 (2002).
  • Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N. Engl. J. Med.341, 949–954 (1999).
  • Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am. J. Respir. Crit. Care Med.172, 613–618 (2005).
  • Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care Med.165, 1217–1239 (2002).
  • Gallagher MJ, Franklin BF, Ehrman JK et al. Comparative impact of morbid obesity vs heart failure on cardiorespiratory fitness. Chest127, 2197–2203 (2005).
  • Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur. J. Heart Fail.9, 251–257 (2007).
  • American Academy of Sleep Medicine (AASM). International Classification of Sleep Disorders. AASM, NY, USA (2005).
  • Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol.99, 1998–2007 (2005).
  • Bixler EO, Vgontzas AN, Lin HM et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med.163, 608–613 (2001).
  • Quan SF, Howard BV, Iber C et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep20, 1077–1085 (1997).
  • Redline S, Tishler PV, Hans MG, Tosteson TD, Strohl KP, Spry K. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am. J. Respir. Crit. Care Med.155, 186–192 (1997).
  • Redline S, Tishler PV. The genetics of sleep apnea. Sleep Med. Rev.4, 583–602 (2000).
  • Kadotani H, Kadotani T, Young T et al. Association between apolipoprotein and sleep disordered breathing in adults. JAMA285, 2888–2890 (2001).
  • Javaheri S, Parker TJ, Liming JD et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation97, 2154–2159 (1998).
  • Corra U, Pistono M, Mezzani A et al. Sleep and exertional periodic breathing in chronic heart failure. Circulation113, 44–50 (2006).
  • Kohnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax57, 547–554 (2002).
  • Andreas S, Hagenah G, Möller C. Cheyne–Stokes respiration and prognosis in congestive heart failure. Am. J. Cardiol.78, 1260–1264 (1996).
  • Lanfranchi PA, Braghiroli A, Bosimini E et al. Prognostic value of nocturnal Cheyne–Stokes respiration in chronic heart failure. Circulation99, 1435–1440 (1999).
  • Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnea–hypopnea with and without treatment with continuous positive airway pressure: an observational study. Lancet365, 1046–1053 (2005).
  • Sin DD, Logan AG, Fitzgerald FS, Liu PO, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne–Stokes respiration. Circulation102, 61–66 (2000).
  • Bradley TD, Floras JS. Sleep apnea and heart failure, part II: central sleep apnea. Circulation107, 1822–1826 (2003).
  • Leon AS, Franklin BA, Costa F et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. Circulation111, 369–376 (2005).
  • Philippe C, Stoica-Herman M, Drouot X et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne–Stokes respiration in heart failure over a six month period. Heart92, 337–342 (2006).
  • Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure trial (CANPAP). Circulation115, 3173–3180 (2007).
  • Lin CC, Lin CK, Wu KM, Chou CS. Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung182, 199–212 (2004).
  • Olson LJ, Somers VK. Treating central sleep apnea in heart failure: outcomes revisited. Circulation115, 3140–3142 (2007).
  • Franklin BA. Fitness: the ultimate marker for risk stratification and health outcomes? Prev. Cardiol.10, 42–45 (2007).
  • Laaban JP, Cassuto D, Orvoen-Frija E et al. Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity. Eur. Respir. J.11, 20–27 (1998).
  • Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch. Intern. Med.167, 757–765 (2007).
  • Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension35, 144–147 (2000).
  • Usui K, Bradley TD, Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J. Am. Coll. Cardiol.45, 2008–2011 (2005).
  • Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax55, 1046–1051 (2000).
  • Aguillard RN, Riedel BW, Lichstein KL, Grieve FG, Johnson CT, Noe SL. Daytime functioning in obstructive sleep apnea patients: exercise tolerance, subjective fatigue, and sleepiness. Appl. Psychophysiol. Biofeedback23, 207–217 (1998).
  • Shifflett ED, Walker EW, Gregg JM, Zedalis D, Herbert WG. Effects of short-term CPAP treatment on endurance exercise performance in obstructive sleep apnea patients. Sleep Med.2, 145–151 (2001).
  • Taguchi O, Hida W, Okabe S et al. Improvement of exercise performance with short-term nasal continuous positive airway pressure in patients with obstructive sleep apnea. Tokohu J. Exp. Med.183, 45–53 (1997).
  • Konermann M, Sanner B, Klewer J et al. Modification of cardiopulmonary parameters in patients with obstructive sleep apnea treated with nCPAP therapy. Wien Med. Wochenschr.146, 340–343 (1996).
  • Salvadori A, Fanari P, Fontana M et al. Oxygen uptake and cardiac performance in obese and normal subjects during exercise. Respiration66, 25–33 (1999).
  • Franklin BA, Kahn JK, Gordon NF, Bonow RO. A cardioprotective ‘polypill’? Independent and additive benefits of lifestyle modification. Am. J. Cardiol.94, 162–166 (2004).
  • Hong S, Dimsdale JE. Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med. Sci. Sports Exerc.35, 1088–1092 (2003).
  • Giebelhaus V, Strohl KP, Lormes W, Lehmann M, Netzer N. Physical exercise as an adjunct therapy in sleep apnea – an open trial. Sleep Breath.4, 173–176 (2000).
  • Alonso-Fernandez A, Garcia-Rio F, Arias MA et al. Obstructive sleep apnoea–hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur. Heart J.27, 207–215 (2006).
  • Bradley TD, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest119, 1827–1835 (2001).
  • Maeder MT, Ammann P, Rickli H et al. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath.12(1), 7–16 (2007).
  • Bonanni E, Pasquali L, Manca ML et al. Lactate production and catecholamine profile during aerobic exercise in normotensive OSA patients. Sleep Med.5, 137–145 (2004).
  • Smart N, Marwick TH. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am. J. Med.116, 693–706 (2004).
  • Solin P, Roebuck T, Johns DP et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am. J. Respir. Crit. Med.162, 2194–2200 (2000).
  • Hanly P, Zuberi N, Gray R. Pathogenesis of Cheyne–Stokes respiration in patients with congestive heart failure: relationship to arterial PCO2. Chest104, 1079–1084 (1993).
  • Naughton M, Benard D, Tam A et al. Role of hyperventilation in the pathogenesis of central sleep apneas in patients with chronic heart failure. Am. Rev. Respir. Dis.148, 330–338 (1993).
  • Francis DP, Davies LC, Willson K et al. Impact of periodic breathing on measurement of oxygen uptake and respiratory exchange ratio during cardiopulmonary exercise testing. Clin. Sci.103, 543–552 (2002).
  • Francis DP, Willson K, Davies LC, Coats AJ, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation102, 2214–2221 (2000).
  • Arzt M, Harth M, Luchner A et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation107, 1998–2003 (2003).
  • Meguro K, Adachi H, Oshima S, Taniguchi K, Nagai R. Exercise tolerance, exercise hyperpnea and central chemosensitivity to carbon dioxide in sleep apnea syndrome in heart failure patients. Circ. J.69, 695–699 (2005).
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365, 1046–1053 (2005).
  • Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur. Respir. J.16, 118–122 (2000).
  • Tkacova R, Dajani HR, Rankin F, Fitzgerald FS, Floras JS, Douglas Bradley T. Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea. J. Hypertens.18, 1257–1262 (2000).
  • Usui K, Parker JD, Newton GE, Floras JS, Ryan CM, Bradley TD. Left ventricular structural adaptations to obstructive sleep apnea in dilated cardiomyopathy. Am. J. Respir. Crit. Care Med.173, 1170–1175 (2006).
  • Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med.348, 1233–1241 (2003).
  • Arias MA, Garcia-Rio F, Alonso-Fernandez A, Mediano O, Martinez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation112, 375–383 (2005).
  • Andreas S, Clemens C, Sandholzer H et al. Improvement of exercise capacity with treatment of Cheyne–Stokes respiration in patients with congestive heart failure. J. Am. Coll. Cardiol.27, 1486–1490 (1996).
  • Egea CJ, Aizpuru F, Pinto JA et al. Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Med. DOI: 10.1016/j.sleep.2007.06.018 (2007) (Epub ahead of print).
  • Hanly PJ, Millar TW, Steljes DG et al. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann. Intern. Med.111, 777–782 (1989).
  • Baratz DM, Westbrook PR, Shah PK, Mohsenifar Z. Effect of nasal continuous positive airway pressure on cardiac output and oxygen delivery in patients with congestive heart failure. Chest102, 31–35 (1992).
  • Bradley TD, Logan AG, Kimoff RJ et al. for the CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med.353, 2025–2033 (2005).
  • Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J. Hypertens.8, 941–946 (1990).
  • Mansfield D, Gollogly N, Kaye D et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med.169, 361–366 (2004).
  • Vogel JA, Franklin BA, Zalesin KC et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am. J. Cardiol.99, 222–226 (2007).
  • Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr. Clin. Pract.22, 22–28 (2007).
  • Spivak H, Hewitt MF, Onn A, Half EE. Weight loss and improvement of obesity-related illness in 500 U.S. patients following laparoscopic adjustable gastric banding procedure. Am. J. Surg.189, 27–32 (2005).
  • Grunstein RR, Stenlof K, Hedner JA, Peltonen M, Karason K, Sjostrom L. Two year reduction in sleep apnea symptoms and associated diabetes incidence after weight loss in severe obesity. Sleep30, 703–710 (2007).
  • Haines KL, Nelson LG, Gonzales R et al. Objective evidence that bariatric surgery improves obesity-related obstructive sleep apnea. Surgery141, 354–358 (2007).
  • Dixon JB, Schachter LM, O’Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int. J. Obes.9, 1048–1054 (2005).
  • Peppard PE, Young T. Exercise and sleep-disordered breathing; an association independent of body habitus. Sleep27, 480–484 (2004).
  • Norman JF, Von Essen SG, Fuchs RH, McElligott M. Exercise training effect on obstructive sleep apnea syndrome. Sleep Res. Online3, 121–129 (2000).
  • Walsh JT, Andrews R, Starling R et al. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive heart failure. Heart73, 237–241 (1995).
  • Guilleminault C, Clerk A, Labanowski M et al. Cardiac failure and benzodiazepines. Sleep16, 524–528 (1993).
  • Biberdorf DJ, Steens R, Millar TW et al. Benzodiazepines in congestive heart failure: effects of temazepam on arousability and Cheyne–Stokes respiration. Sleep16, 529–538 (1993).
  • Dowdell WT, Javaheri S, McGinnis W. Cheyne–Stokes respiration presenting as sleep apnea syndrome. Am. Rev. Respir. Dis.141, 871–879 (1990).
  • Dowdell AR, Keyman A, Sieker HO, Tripathy K. Effect of aminophylline on respiratory center sensitivity in Cheyne–Stokes respiration and in pulmonary emphysema. N. Engl. J. Med.273, 1447–1453 (1965).
  • Moyer JH, Miller SI, Tashnek AB, Bowman R. Effect of theophylline with ethylenediamine (aminophylline) on cerebral hemodynamics in the presence of cardiac failure with and without Cheyne–Stokes respiration. J. Clin. Invest.31, 267–272 (1952).
  • Javaheri S, Parker TJ, Wexler L et al. Effect of theophylline on sleep disordered breathing in heart failure. N. Engl. J. Med.335, 562–567 (1996).
  • Mulloy E, McNicholas WT. Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest101, 753–757 (1992).
  • Guilleminault C, Hayes B. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea. Negative results. Bull. Eur. Physiopathol. Respir.19, 632–634 (1983).
  • Bradshaw DA, Ruff GA, Murphy DP. An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea. Chest130, 1369–1376 (2006).
  • Weil JV, Kryger MH, Scoggin CH. Sleep and breathing at high altitude. In: Sleep Apnea Syndrome. Guilleminault C, Dement WC (Eds). Alan R. Liss, NY, USA 113–136 (1978).
  • White DP, Zwillich CS, Pickett CK et al. Central sleep apnea: improvement with acetazolamide therapy. Arch. Intern. Med.142, 1816–1819 (1982).
  • Rotzenblatt S, Guilleminault C, Poyares D, Cintra F, Kauati A, Tufik S. A double-blind, placebo-controlled, crossover study of sildenafil in obstructive sleep apnea. Arch. Intern. Med.166, 1763–1767 (2006).
  • Keating GM, Raffin MJ. Modafinil: a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs19, 785–803 (2005).
  • Schwartz JR, Hirshkowitz M, Erman MK, Schmidt-Nowara W. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest124, 2192–2199 (2003).
  • Gothe B, Strohl KP, Levin S, Cherniack NS. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest87, 11–17 (1985).
  • Hanzel DA, Proia NG, Hudgel DW. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest100, 416–421 (1991).
  • Veasey SC. Pharmacotherapies for obstructive sleep apnea: how close are we? Curr. Opin. Pulm. Med.7, 399–403 (2001).
  • Carley DW, Olopade C, Ruigt GS, Radulovacki M. Efficacy of mirtazapine in obstructive sleep apnea syndrome. Sleep30, 35–41 (2007).
  • Ozturk LM, Metin G, Cuhadaroglu C, Utkusavas A, Tutluoglu B. Cardiopulmonary responses to exercise in moderate-to-severe obstructive sleep apnea. Tuberk. Toraks.53, 10–19 (2005).
  • Vanuxem D, Badier M, Guillot C, Delpierre S, Jahjah F, Vanuxem P. Impairment of muscle energy metabolism in patients with sleep apnoea syndrome. Respir. Med.91, 551–557 (1997).
  • Grote L, Hedner J, Peter JH. The heart rate response to exercise is blunted in patients with sleep-related breathing disorder. Cardiology102, 93–99 (2004).
  • Schönhofer B, Rosenblüh J, Voshaar T, Köhler D. Ergometry separates sleep apnea syndrome from obesity-hypoventilation after positive pressure ventilation therapy. Pneumologie51, 1115–1119 (1997).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.